Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Antares Pharma To Be Acquired by Halozyme

Skadden is advising Antares Pharma, Inc. on its $1 billion acquisition by Halozyme Therapeutics, Inc.
BACK TO TOP